急诊药师对急性缺血性卒中溶栓门-针时间的影响:系统评价与荟萃分析
该系统评价与荟萃分析检索多个数据库,纳入9项观察性回顾性队列研究、共1064例接受纤溶治疗的成人急诊急性缺血性卒中患者,其中急诊药师在场组441例(41.4%)、不在场组623例(58.6%)。急诊药师在场与平均门-针时间缩短14.6分钟相关(95%CI -18.1至-11.1分钟),门-针时间≤60分钟和≤45分钟的达标几率更高,OR分别为2.85(95%CI 1.40-5.79)和2.75(95%CI 1.99-3.79)。急诊药师在场组ICU住院时间延长2.07天,但两组医院总住院时间无差异。作者认为急诊药师在场与门-针时间缩短相关,强调急诊药师在优化卒中救治中的重要性。
要点
- 急诊药师在场组平均门-针时间较不在场组缩短14.6分钟(95%CI -18.1至-11.1分钟)。
- 急诊药师在场组门-针时间≤60分钟达标几率更高,OR 2.85(95%CI 1.40-5.79)。
- 急诊药师在场组门-针时间≤45分钟达标几率更高,OR 2.75(95%CI 1.99-3.79)。
- 急诊药师在场组ICU住院时间较不在场组延长2.07天,但医院总住院时间两组无差异。
- 证据来自9项观察性回顾性队列研究、共1064例患者,急诊药师在场组441例(41.4%)、不在场组623例(58.6%)。
适用人群与场景
- 成人急诊科急性缺血性卒中并接受纤溶治疗的患者,且研究中定义了急诊药师参与。
诊断标准与关键阈值
- 纳入标准:成人急诊患者、急性缺血性卒中、接受纤溶治疗、有明确的急诊药师参与定义。
研究设计与关键结果
- 研究类型:系统评价与荟萃分析,纳入9项观察性回顾性队列研究,共1064例患者。
- 分组:急诊药师在场组441例(41.4%),急诊药师不在场组623例(58.6%)。
- 主要终点:急诊药师在场与平均门-针时间缩短14.6分钟相关(95%CI -18.1至-11.1分钟)。
- 次要终点:门-针时间≤60分钟达标率OR 2.85(95%CI 1.40-5.79);门-针时间≤45分钟达标率OR 2.75(95%CI 1.99-3.79)。
- 住院时间:急诊药师在场组ICU住院时间延长2.07天,医院总住院时间两组无差异。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,纳入9项观察性回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为急诊药师在场与急性缺血性卒中纤溶门-针时间缩短相关,强调急诊药师在优化卒中救治中的重要性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute ischemic stroke (AIS) requires time-sensitive fibrinolytic therapy measured by door-to-needle (DTN) time. Emergency medicine pharmacists (EMPs) are integral in emergency departments (EDs) for optimizing AIS care as they possess expertise in drug therapy and emergency response.
OBJECTIVE: The purpose of this systematic review and meta-analysis (SR/MA) is to evaluate EMP impact on DTN time.
METHODS: This SR/MA searched multiple databases. Eligibility criteria included adult ED patients with AIS receiving fibrinolytics with defined EMP involvement. The primary endpoint was fibrinolytic DTN time. Secondary endpoints included achievement of timely fibrinolytic and length of stay (LOS). Meta-analysis was conducted using random-effects models.
RESULTS: Of 494 total citations identified, 214 citations met screening criteria with 22 studies undergoing full text review and 9 observational, retrospective, cohort studies included. A total of 1064 patients were included for MA with 441 (41.4 %) in the EMP present group and 623 (58.6 %) in the EMP absent group. EMP presence was associated with reduced mean DTN time by 14.6 min (95 % CI -18.1, -11.1 min). Odds of achieving a DTN within 60- and 45-min was higher with EMP presence, OR 2.85 (95 % CI 1.40, 5.79) and 2.75 (95 % CI 1.99, 3.79), respectively. ICU LOS was longer by 2.07 days in the EMP present group, but hospital LOS was not different between groups.
CONCLUSIONS: EMP presence during AIS management is associated with a reduction in fibrinolytic DTN time compared to no EMP presence. These findings highlight the importance of EMPs in optimizing patient outcomes related to stroke care.
参考来源
- Mercer KJ, Howington GT, Brown CS, et al. Assessing the impact of emergency medicine pharmacists on fibrinolytic door-to-needle times in acute ischemic stroke: A systematic review and meta-analysis (Pharmacist-assisted Stroke Treatments I (PhAST-1)). Am J Emerg Med. 2025. PMID: 40840401. doi:10.1016/j.ajem.2025.08.014
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。